Oncology Global Pharma Manufacturer Perception Tracker Oncology Every day, over 54,500 people are diagnosed with cancer—and more than 26,000 succumb. Pharma leaders are answering the call by increasing investments in cancer drug research and developing personalized treatments,
Promotional Tracking Global Pharma Manufacturer Perception: Vaccines The vaccine industry has undergone an unprecedented transformation in the last 5 years, driven by significant technological advancements and a renewed global focus on public health and immunization. Breakthroughs in multiple areas like
Promotional Tracking Factor XIa Inhibitors for NVAF - Cardiologists' Perspectives Key Findings •Eliquis is currently the top choice for stroke prevention in NVAF, being used in 56% of patients, followed by Xarelto at 26% • Mirroring usage, 77% of cardiologists perceive Eliquis as performing
Promotional Tracking Four Myths in HCP-Sales Rep Engagements Stirring the Hornet’s Nest Engaging with healthcare professionals (HCPs) through sales representative interactions is like a delicate dance. There are established norms & firm beliefs on how it is being done. Challenging those
Promotional Tracking Thriving Against the Odds - A Case study An Emerging Biopharma’s David vs. Goliath story in the Post Launch Space Problem: Respiratory diseases are one of the leading causes of death and hospital admissions in the US. This market is
Promotional Tracking Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape Highlight products’ superiority and differentiability Your browser does not support the audio element. Answer questions and/or solve problems Your browser does not support the audio element. Deliver newer data, such as product
President Biden Signed a $1.7 Trillion Spending Bill; Here’s What It Means for Your Healthcare Just before funding for the federal government was set to expire, President Joe Biden signed the Consolidated Appropriations Act of 2023. The nearly $1.7 trillion federal spending bill averts a government shutdown
Research Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021 Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions. In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists
